FDA approves novel treatment for liver disease
For the millions of Americans living with nonalcoholic fatty liver disease, the newly approved drug Rezdiffra (resmetirom) offers hope for an optimistic future.
More from Washington College Newspapers
Daily Evergreen | Washington State
Beyond the blue line: Van Rayner reaches historic 100 games played
Washington College Newspapers
•
9h ago
Daily Evergreen | Washington State
On the horizon: Women's baketball nears the start of the season
Washington College Newspapers
•
11h ago
Daily Evergreen | Washington State
WSU volleyball falls to Fresno State in five
Washington College Newspapers
•
1d ago
Daily Evergreen | Washington State
Cougar football continues losing streak in loss to Oregon State
Washington College Newspapers
•
1d ago
Daily Evergreen | Washington State
WSU will not change Title IX policies, despite Trump changes
Washington College Newspapers
•
2d ago
Daily Evergreen | Washington State
Cougars reverse sweep Broncos to get back to .500
Washington College Newspapers
•
3d ago
Daily Evergreen | Washington State
New study lounge in Terrell Library
Washington College Newspapers
•
4d ago
Daily Evergreen | Washington State
Sen. Patty Murray Formally Launches Public Health for America Working Group
Washington College Newspapers
•
4d ago